In 49 study comparisons, ANDROMEDA by Prosilico outperformed laboratory methods in 74 % of cases (on par in 22 % of cases) and had >30-fold lower max prediction error. Read our recent publication In Silico Prediction of Human Clinical Pharmacokinetics with ANDROMEDA by Prosilico: Predictions for an Established Benchmarking Data Set, a Modern Small Drug Data Set, and a Comparison with Laboratory Methods. ATLA 2023.
https://journals.sagepub.com/doi/abs/10.1177/02611929221148447?journalCode=atla
